Daidzein

Category
flavonoid
Routes
Oral (PO)
Half-Life (t½)
PO: 7.8h
Formula
C15H10O4
Molecular Weight
254.24 g/mol
PubChem CID
5281708
Aliases
7,4′-dihydroxyisoflavone

Pharmacological Mechanism

Isoflavone phytoestrogen — binds ER-β preferentially (10–20× over ER-α). Gut microbial conversion by Slackia isoflavoniconvertens / Adlercreutzia equolifaciens yields S-equol, the more active metabolite — only ~25–50% of adults are 'equol producers' depending on gut composition, which explains much of the clinical heterogeneity in soy studies.

Half-Life & Elimination Curve (PO: 7.8h)

100%50%25%12.5%0%0h0×t½7.8h1×t½15.6h2×t½23.4h3×t½31.2h4×t½39h5×t½0×t½ (0h): 100% remaining (~0.463 mg/L)1×t½ (7.8h): 50% remaining (~0.231 mg/L)2×t½ (15.6h): 25% remaining (~0.116 mg/L)3×t½ (23.4h): 12.5% remaining (~57.9 µg/L)4×t½ (31.2h): 6.3% remaining (~28.9 µg/L)5×t½ (39h): 3.1% remaining (~14.5 µg/L)
Plasma (PO)t½ Decay (7.8h)
  • 0×t½0h100% (0.463 mg/L)
  • 1×t½7.8h50% (0.231 mg/L)
  • 2×t½15.6h25% (0.116 mg/L)
  • 3×t½23.4h12.5% (57.9 µg/L)
  • 4×t½31.2h6.3% (28.9 µg/L)
  • 5×t½39h3.1% (14.5 µg/L)
Elimination t½7.8h (PO)
Rate Constant (ke)0.0889 h⁻¹
Time to Peak (Tmax)3.09h
Est. Peak (Cmax)0.463 mg/L
Clearance (CL)3.11 L/h
97% Washout (5×t½)39h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References